Cannabis Investors: 2 Canadian Pot Stocks That Will Be Profitable in 2020

While several pot stocks are struggling with mounting losses, two Canadian cannabis companies are reporting strong profit margins.

| More on:
Female scientist in a hemp field checking plants and flowers, alternative herbal medicine concept

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

We have seen that most marijuana stocks have decimated investor wealth in 2019.  The ongoing slowdown has been exacerbated with less than impressive earnings. The sell-off in the cannabis space started soon after recreational marijuana was legalized in October 2018.

Investors were then concerned over the high valuations of cannabis companies. The cannabis dream for investors soon turned into a nightmare as they failed to account for the slow rollout of retail stores across major Canadian provinces as well as the cannibalization of market share from illegal sellers.

This, coupled with rising losses have sent marijuana companies to multi-year lows. However, it’s entirely possible that a few stocks have now bottomed out and might move higher as we inch closer to 2020.

Here we look at two pot stocks that will not only grow sales at a robust pace, but will also inspire investor confidence with rising profit margins.

Aphria estimated to post adjusted earnings of $0.05 in fiscal 2020

Shares of Canada’s leading cannabis company Aphria (TSX:APHA) are trading at $6.2 at writing. The stock has declined 72% since January 2018. Aphria went public on December 12, 2014, and closed trading at $0.75 that day. This means the stock has gained an impressive 725% in the last five years despite the recent pullback.

Aphria sells cannabis products targeting medical marijuana as well as the recreational marijuana space. It accounts for 8.5% of the Horizons Marijuana Life Sciences ETF and is the fourth largest holding in the ETF.

Analysts expect Aphria sales to rise 149% to $591 million in fiscal 2020 (year ending in May), 35% to $800 million in 2021 and 15% to $921 million in 2022. Though revenue growth is decelerating, Aphria is already reporting an adjusted profit.

Analysts expect company earnings to rise from -$0.07 in 2019 to $0.05 in 2020 and $0.25 in 2021, suggesting that the stock’s forward price to earnings multiple stands at 26, which is cheap given its robust growth metrics.

Aphria is expected to post EBITDA of $49.9 million in 2020, indicating a margin of 8.4%. EBITDA is then estimated to rise to $197 million in 2022, expanding the margin to a healthy 21.4%.

Charlotte’s Web Holdings

Another pot stock that will soon be profitable is Charlotte’s Web Holdings (TSX:CWEB). CWEB focuses on the production and distribution of hemp-based cannabidiol wellness products. It’s one of the few companies to solely focus on the medical wellness space.

However, CWEB investors have also experienced a massive erosion in market value. The stock went public on May 31 this year and closed trading at $17.88 that day. It then rose to a record high of $30.1 in August and has slumped over 60% since then to its current trading price of $11.95.

Analysts expect CWEB sales to rise 41% to $99 million in 2019, 49.5% to $148 million in 2020 and 85% to $274 million in 2021. CWEB’s revenue growth is accelerating helping the firm to grow its bottom line.

CWEB is expected to post EBITDA of $8.9million in 2019, indicating a margin of 8.3%. Its EBITDA is then estimated to rise to $72.8 million in 2021 increasing margins to almost 27%.

CWEB’s growth will be supported by its expansion of retail partnerships. Company products are already available at 9,000 retail store locations.

CWEB is the eighth largest holding in HMMJ and accounts for 6.2% of the ETF.

The cannabis growth story remains strong

The total addressable market for cannabis continues to expand globally. Aphria estimates the global marijuana market to be valued at $150 billion by 2025.

Most pot stocks will get a significant boost if and when the U.S. Senate legalizes marijuana consumption at the federal level, which will provide pot companies with easier access to capital for growth and expansion.

Aphria and CWEB can be market leaders in the cannabis space given their robust margin growth and increase investor wealth over the next decade.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool owns shares of and recommends Charlotte's Web Holdings. Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Stock: The Only Cannabis Stock to Consider Long Term

The cannabis stock industry remains an incredibly high risk one, but Canopy Growth (TSX:WEED)(NYSE:CGC) stock provides the best opportunity for…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why Did Aurora Cannabis (TSX:ACB) Stock Plunge 75% in 2022?

A prominent cannabis stock has plunged by 75% in 2022, as the company’s losses continue to mount in the face…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Fire & Flower: A Small Pot Stock Poised for Strong Growth

Fire & Flower is a cannabis retailer well-positioned for growth thanks to its digital and delivery initiatives.

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Is Sinking This Week

Starting another round of capital raising has hurt investor sentiments, and the Canadian cannabis giant’s performance on the stock market…

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Canopy Growth (TSX:WEED) Stock Plunged 19% Last Week

Canopy Growth Corp. (TSX:WEED)(NASDAQ:CGC) stock has plunged after the release of its final fiscal 2022 results.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Tanked 45% Last Week

There's no respite for Aurora Cannabis investors!

Read more »

Money growing in soil , Business success concept.
Cannabis Stocks

TFSA Investors: This Undervalued Gem Could Turn $6,000 Into $25,000

Here's why TFSA investors can hold undervalued growth stocks such as Verano in their portfolios right now.

Read more »